These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10027 related articles for article (PubMed ID: 1532342)

  • 1. Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growth in vitro.
    Darrow TL; Wahab Z; Quinn-Allen MA; Seigler HF
    Cancer; 1992 Apr; 69(7):1843-9. PubMed ID: 1532342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
    J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
    Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K
    Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinoma.
    Peyret C; Bochner BH; Lee TY; Koo AS; deKernion JB; Belldegrun A
    J Surg Res; 1992 Dec; 53(6):602-9. PubMed ID: 1494294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
    Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.
    Chakraborty NG; Sporn JR; Pasquale DR; Ergin MT; Mukherji B
    Clin Immunol Immunopathol; 1991 Jun; 59(3):407-16. PubMed ID: 2029793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
    Melioli G; Guastella M; Semino C; Meta M; Pietra G; Ponte M; Queirolo P; Sertoli MR; Martini L; Reali UM
    Melanoma Res; 1994 Apr; 4(2):127-33. PubMed ID: 8069098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.
    Grimm EA; Bruner JM; Carinhas J; Köppen JA; Loudon WG; Owen-Schaub L; Steck PA; Moser RP
    Cancer Immunol Immunother; 1991; 32(6):391-9. PubMed ID: 1848799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
    Guilloux Y; Viret C; Gervois N; Le Dréan E; Pandolfino MC; Diez E; Jotereau F
    Eur J Immunol; 1994 Sep; 24(9):1966-73. PubMed ID: 7522155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
    Liu S; Etto T; Rodríguez-Cruz T; Li Y; Wu C; Fulbright OJ; Hwu P; Radvanyi L; Lizée G
    J Immunother; 2010 May; 33(4):371-81. PubMed ID: 20386469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N; Heuze F; Diez E; Jotereau F
    Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of tumor infiltrating lymphocyte clones derived from B16-F10 murine melanoma.
    Maeda K; Lafreniere R; Jerry LM
    J Invest Dermatol; 1991 Aug; 97(2):183-9. PubMed ID: 2071934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
    Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
    Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4.
    Lindgren CG; Thompson JA; Higuchi CM; Fefer A
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):322-8. PubMed ID: 8280715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of CD4+ T helper cell clones in human melanoma.
    Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
    Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of growth, phenotype and cytotoxic activity of tumor infiltrating lymphocytes expanded in vitro with interleukin-2 and interleukin-4: preliminary results].
    Manna R; Cristiano G; Severino Martin L; Emerentienne Sambakay C; Liang LI; Crucitti F; Iudicone P; Salgarello G; Gambassi G; Quintiliani L
    Ann Ital Med Int; 1992; 7(1):19-25. PubMed ID: 1388039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes.
    Kuge S; Watanabe K; Makino K; Tokuda Y; Mitomi T; Kawamura N; Habu S; Nishimura T
    Jpn J Cancer Res; 1995 Feb; 86(2):135-9. PubMed ID: 7730135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
    Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
    Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.
    Aebersold P; Hyatt C; Johnson S; Hines K; Korcak L; Sanders M; Lotze M; Topalian S; Yang J; Rosenberg SA
    J Natl Cancer Inst; 1991 Jul; 83(13):932-7. PubMed ID: 2067036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production.
    Becker JC; Schwinn A; Dummer R; Burg G; Bröcker EB
    J Invest Dermatol; 1993 Jul; 101(1):15-21. PubMed ID: 8331293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 502.